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Amphibians across the planet face the threat of population decline and extir-
pation caused by the disease chytridiomycosis. Despite consensus that the
fungal pathogens responsible for the disease are conservation issues, strat-
egies to mitigate their impacts in the natural world are, at best, nascent.
Reducing risk associated with the movement of amphibians, non-amphibian
vectors and other sources of infection remains the first line of defence
and a primary objective when mitigating the threat of disease in wildlife.
Amphibian-associated chytridiomycete fungi and chytridiomycosis are
already widespread, though, and we therefore focus on discussing options
for mitigating the threats once disease emergence has occurred in wild
amphibian populations. All strategies have shortcomings that need to be
overcome before implementation, including stronger efforts towards under-
standing and addressing ethical and legal considerations. Even if these
issues can be dealt with, all currently available approaches, or those under
discussion, are unlikely to yield the desired conservation outcome of disease
mitigation. The decision process for establishing mitigation strategies
requires integrated thinking that assesses disease mitigation options criti-
cally and embeds them within more comprehensive strategies for the
conservation of amphibian populations, communities and ecosystems.
This article is part of the themed issue ‘Tackling emerging fungal threats
to animal health, food security and ecosystem resilience’.1. Introduction
We are confronting an expanding array of pathogenic fungi that cause extensive
mortality, demographic decline and extirpations in livestock, crop and wildlife
hosts [1]. Developing strategies to limit the spread and impact of these patho-
gens is a priority that crosses the boundaries of politics, economics, science
and health, and falls within the remit of the medical, veterinary, agricultural
and conservation sciences. Despite the increasing range of animal and plant
taxa threatened by fungal pathogens, conservation science has not advanced
disease mitigation in nature as a priority. This shortcoming has no better
example than research on amphibian-associated chytridiomycete fungi. Our
recognition of the threat posed by the global and regional emergences of the
chytrid Batrachochytrium dendrobatidis (hereafter, Bd), has spurred significant
advances in understanding the biology of the fungus and the dynamics of chy-
tridiomycosis since the disease was first identified nearly 20 years ago [2].
(b)(a)
Figure 1. Examples of lethal chytridiomycosis from Latin America (a) and Europe (b). (a) A Craugastor underwoodi dead and in situ killed by lethal chytridiomycosis
in Monte Verde, Costa Rica. The isolate derived from this animal in 2008 has served as the source of DNA for real-time polymerase chain reaction (qPCR)–positive
controls for two of the authors to this day. (b) An Alytes muletensis, again dead and in situ, found on Mallorca, Spain.
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pean emergence of another chytrid fungus, Batrachochytrium
salamandrivorans (Bsal) [3]. Unfortunately, the development
of field interventions for disease management has lagged
far behind and managing amphibian health in nature
remains a largely unexplored topic [4–6]. Because applied
conservation always operates under enormous financial con-
straints, it is important to critically assess the viability of
conservation strategies before significant investment, which
has rarely been done for strategies for controlling chytridio-
mycosis in wild amphibians [6–8]. Here, we assess some of
the commonly proposed approaches to control the spread
and impact of amphibian chytridiomycosis in the field.
We assume that an ideal strategy will be: (i) safe, legal and
ethical, (ii) effective and reliable, (iii) transferrable across
host species, communities and environments, (iv) relatively
simple to implement, and (v) cost-effective.
Countering disease-driven amphibian declines should
consist of a multifaceted approach adapted to the stages of
pathogen emergence (pre-arrival, invasion front, epidemic
and established) [9]. Current approaches include prevention
and short-term solutions (e.g. ex situ breeding programmes,
cryopreservation) but long-term, in situ, sustainable solutions
are required if the goal of amphibian conservation is to be
attained. This implies neutralizing the disease threat in wild
populations. Although we do not discuss the prevention of
pathogen introduction here in any detail, attempts to do
this (e.g. via trade regulations, such as the recent establish-
ment of restrictions on caudate amphibian trade in the USA
in response to the emergence of B. salamandrivorans,
https://federalregister.gov/a/2016-00452) are probably the
most effective disease mitigation measure available [9,10].
The international movement of amphibians plays a continu-
ing role in establishing and extending the distribution of
amphibian-associated chytrids and other pathogens, but the
control of chytridiomycosis and other purely wildlife dis-
eases is largely overlooked in commercial trade [3,11–13].
The World Organisation for Animal Health (OIE) is the inter-
national body that can regulate this, but even though its remit
includes wildlife conservation it has a poor track record in
doing so. Batrachochytrium dendrobatidis has been listed by
the OIE but enforcement of chytridiomycosis control in the
amphibian trade has not been implemented by OIE
member states [14].Here, we review strategies for mitigating amphibian dis-
ease following pathogen emergence. These range from
minimizing effects on host populations to pathogen eradica-
tion. Short-term solutions have been discussed in detail or
summarized elsewhere and these are considered vital in
temporarily preserving amphibian populations at risk
[4,6,15,16]. For example, interventions with antifungals
during an epidemic can alter infection dynamics and alleviate
disease, but in the absence of long-term disease management
in situ, any short-term measure is unlikely to result in signifi-
cant conservation success [17]. We focus on measures that
offer the potential for long-term chytridiomycosis manage-
ment in situ. Bd currently infects hundreds of amphibian
species on all continents where amphibians occur (figure 1)
[18]. Amphibian infections with Bd predate the late twentieth
century identification of lethal chytridiomycosis, and global
emergence of the lethal form of the disease at this time was
widespread [19,20]. Chytridiomycosis continues to emerge
across four continents, precluding its elimination from wide-
spread and complex infected host communities [18]. Instead
of focusing on short-term solutions, we examine a more prag-
matic approach that strives for long-term, host–pathogen
coexistence. An ambitious aim would be to preserve a maxi-
mum proportion and diversity of amphibian species across as
many of their distributions as possible. This implies that
conservation triage will be necessary, accepting the loss of
individual populations and even species [21,22]. Indeed,
culling of reservoir and superspreader hosts requires con-
sideration (figure 2). Irrespective, aims and methods will
depend on local conservation priorities and should be
defined by local conservation managers [24].
Amphibian chytridiomycosis treatments have been
developed for captive populations, but translating these to
managing infections in wild amphibian populations and com-
munities is not straightforward. This is because amphibians
affected by chytridiomycosis occupy terrestrial, arboreal,
aquatic and subterranean habitats that can overlap in a
single landscape. Host population sizes fluctuate enormously,
often exhibit highly dynamic spatial dispersion, and are fre-
quently undetectable for much of the year. Therefore, it is
not surprising that the number of studies of infection and dis-
ease in the wild, and those exploring management of infection
in captivity, far outstrip those on in situ intervention. We know
of few published studies describing the outcomes of attempted
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Figure 2. The relative impact of culling and antifungal treatment in a simple, single-species population paramaterised using data on the Mallorcan midwife toad.
Mitigation is undertaken at point m. See [23] for explanation of model structure and parameter estimation. (a) Culling of tadpoles, undertaken at point m, results in
pathogen elimination. The yellow line is adult population size and the red line is free-swimming zoospore density. (b–c) Comparison between culling and tadpole
antifungal treatment and release, assuming maintenance of infection in the adult population and keeping model parameters identical across models. Here, green
lines are adult population size and blue lines are free-swimming zoospore density. In (b), mitigation is unsuccessful due to increased host density after treated
tadpoles are returned to the pond. In (c), pathogen elimination is attributable to more persistent reduction in host density.
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strategies to mitigate the impacts of chytridiomycosis in
nature have been attempted and published: translocation/
reintroduction, augmentation of the host microbiome with
probiotics, treatment of individuals with antifungals and a
combination of antifungal treatment with chemical disinfection
of the environment [16,17,25–27].2. Trialled and tested
Translocations/reintroductions often have strong appeal
because they can promote the idea that ‘something is being
done’. They are erroneously perceived to be cost-effective,
simple to implement and transferrable. However, without a
solid understanding of host–pathogen dynamics and the
biology of the host and pathogen in the landscape, transloc-
ations/reintroductions have little probability of success. Several
attempts have been made to repatriate amphibians affected by
chytridiomycosis in Europe, North America, the Caribbean
andAfrica but none have led to successful, long-term amphibian
re-establishment [4,26,28,29] (but see [30] for evidence of short-
term post-release survival). Although the majority of failures
have been associated with the re-emergence of lethal chytridio-
mycosis in the translocated/reintroduced species, the cause
behind failure to re-establish in almost every case could not be
attributed clearly [26,28] (but see [11]). This is important because
lethal chytridiomycosis can be a secondary consequence of other
threatening processes, which would mean conservation efforts
focused on the fungus could be misdirected [28,29,31]. Theinability to unambiguously identify cause demonstrates the rela-
tive immaturity of the science of amphibian reintroduction as a
means of mitigating chytridiomycosis, falsifies the assumptions
of simplicity and transferability, and violates the requirement
of threat mitigation before reintroduction [32]. It also calls for
greater investment in pathological investigations in concert
with post-release field monitoring. Given our incomplete under-
standing of Bd dynamics and the potential for development of
resistance to Bd in wild populations, the use of translocations/
reintroductions as a research tool is perhaps more appropriate
than as a mitigation strategy against Bd.
A decade ago, Harris and co-workers discovered that a
subset of bacteria isolated from the skin of living amphibians
has the ability to inhibit Bd growth in vitro [33]. Since then bac-
teria that inhibit Bd have been isolated from amphibians from
across the Americas, Africa, Europe and Australia. Field studies
of amphibian microbiomes indicate that the bacterial commu-
nity on amphibian skin changes with amphibian life-history
stage, with fewer Bd-inhibitory species in later life stages,
suggesting that targets for field intervention may be age-specific
[34]. An expanding research programme is underway to ascer-
tain if resistance to or limitation of infection can be enhanced by
augmenting amphibian skin microbiomes with inhibitory bac-
teria. Encouragingly, a limited, but successful, field trial has
been published along with a strategy for the isolation and
potential application of probiotics to augment skin microbiomes
[25,35]. This strategy outlines the advantages of bioaugmenta-
tion, including the use of local bacterial isolates, and describes
the potential for environmental application of bacteria that
will interact with an entire amphibian community [35].
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tics can be considered a viable mitigation strategy. First, the
potential risk probiotics pose to ecosystem and public health
requires assessment and the practicalities of probiotic develop-
ment are also largely unassessed [36]. For example, there is
little available information regarding the relationship between
chytrid growth inhibition in vitro and effective inhibition of
fungal growth or the development of disease in vivo. Exper-
imental efforts using probiotics to control Campylobacter in
poultry show that the relationship will probably not be
straightforward and that some bacteria that are inhibitory are
ineffective against pre-existing infections [37,38]. Efficient
and persistent host and environmental colonization needs to
be established: amphibian skin microbiomes are dynamic
and can be unstable and unpredictable, and bacterial commu-
nity composition changes over the animal’s lifetime [32].
Bioaugmentation requires a deeper understanding of bacterial
community assembly, stability and permeability, couched in
the context of amphibian host community, the skin secretions
produced by species members of the community and how
these are in turn influenced by environmental heterogeneity
[39,40]. Probiotics should also exert their beneficial effect
across Bd genotypes. It has already been documented that
the ability to inhibit one isolate of Bd does not translate
across different isolates of the globally pandemic lineage
[41]. Finally, a probiotic should show characteristics that
render it suitable for mass production, including prolonged
shelf life. As it stands, we have an unclear understanding of
how interactions among all these factors will influence the
development of effective probiotic therapies against chytridio-
mycosis. The research required to gain this understanding will
probably be less cost-effective, implementable and transfer-
rable than that for chemical treatments (see below), and, if
animal experiment requirements are extensive and not well-
justified, ethically questionable. However, if candidate bacteria
can be characterized that meet the required criteria, their appli-
cation could be far more cost-effective, ethical and less
controversial than chemical treatment.
Antifungals applied directly to susceptible hosts have
proved ineffective as a long-term strategy for in situ chytrid
mitigation, as they afford no persistent benefits after treat-
ment is stopped [17,27]. However, in an isolated and
structurally simple ecosystem containing a single amphibian
host species, antifungal treatments of individuals combined
with chemical treatment of the environment did eliminate
Bd and clearance persisted across years [27]. These findings
suggest that the environmental application of fungicides
may be a viable, cost-effective, simple to implement and
broadly transferrable strategy for controlling infection in
some wild amphibian populations. Environmental treatment
might not be applicable to many amphibian communities
and species, however, and the environmental application
of chemical pesticides has significant ecological, legal and
ethical ramifications. To be effective in the long term, fungi-
cides may have to be applied on a regular basis, much as
they are in agricultural systems. Although any strategy that
requires ongoing maintenance and has the potential for col-
lateral impacts might seem untenable, decades of fungicide
applications to food crops have had a significant and positive
effect on global food yields [42]. The parallel suggests that in
the face of the chytridiomycosis crisis environmental treat-
ment with fungicides should be considered as a viable,
long-term management strategy for wild amphibiansthreatened by the disease. Very little effort has been
expended in investigating existing chemical compounds
that are effective against amphibian-associated chytrids, or
the development of chemical agents that specifically target
chytrids, despite the evidence that some chemical pesticides
mitigate infection in the aquatic environment without com-
promising amphibian development and larval survival [43]
(but see [44]). Although the use of agricultural pesticides is
greatly debated, the focal, short-term application of antifun-
gals targeted at a reduction of infection prevalence and
infection load in specific cases of acute chytridiomycosis-
driven amphibian die-offs is worth exploring [45]. The
application of any such measure should be weighed against
its potential negative impacts on biodiversity, ecosystem
function, human health and the potential for amphibian-
associated chytrids to develop resistance to these treatments
[46]. Advances in our understanding of the virulence factors
and cellular components key for chytrid reproduction,
growth and infectivity should inform the selection of com-
pounds that exhibit multi-modal antifungal action, and also
guide the development of application strategies [47,48].3. Horizon-scanning or wishful thinking?
Several mitigation strategies are gaining traction in the litera-
ture although they remain untested in real-world settings.
Evidence is accumulating that at least some species are
responding to the emergence of chytridiomycosis through
natural selection on immunity [49,50]. As a result, two argu-
ments that incorporate selection into mitigation strategies
are being promoted [51]. The first is based on the idea that,
given time, natural selection will operate on immunogenetic
variation in amphibian populations. To enable this, amphi-
bians need to persist in the face of the pathogen, and
translocation/repatriation has been proposed as a method to
facilitate population persistence during the process of selec-
tion. The second strategy is to breed selectively for resistant
or tolerant genotypes for release into the wild [52]. Both
strategies seek to establish resistant or tolerant populations
and are based on the assumptions that amphibian host
immune responses to chytrids can be selected for and that
immune function will be protective in a wild setting.
We can apply the points for and against translocations/
reintroductions that we outlined above to the strategy of trans-
location/repatriation, compounded with the need to
understand resistance and tolerance in captive populations
before any release could be ethically undertaken. But what
about selective breeding? We are aware of a single example
where captive selection and subsequent breeding created
defined lines that exhibit variation in immunity in an amphi-
bian: the genus Xenopus [53,54]. The knowledge base on
Xenopus captive breeding, cell biology, genetics and immunity
took decades to develop. Advances are being made in com-
parative immunogenetics that could conceivably guide
breeding designs, but this is still a long way from understand-
ing host species immune responses to chytrids and exploring
heritable variation of amphibian immunity with the goal of
selective breeding [55]. The elucidation of mechanisms under-
pinning resistance against Bd would greatly facilitate the
development of resistance markers that could be used in
marker-assisted selective breeding programmes. The chances
of finding any such marker, or a set of markers, are hampered
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host [56]. Establishing captive colonies upon which selection
can be imposed is a non-trivial task and requires extensive
investment and resources. Even if assisted selection does pro-
duce genotypes that have the ability to resist or tolerate
infection with chytrids, there is no guarantee that these abil-
ities will function when transferred to a natural setting.
Research has repeatedly shown how environmental variation
can dictate the outcome of the amphibian host/chytrid patho-
gen interaction and the ability to mount innate immune
responses to Bd can be significantly impaired simply by mod-
ifying ambient temperature [31,56–59]. We do not dismiss the
possibility that assisted selection might provide conservation
benefits, only caution that the current knowledge base indi-
cates significant research is still required before natural and
assisted selection can be applied widely to chytrid mitigation.
If genetic determinants of host resistance are identified in mul-
tiple amphibian species and new technologies for genetic
manipulation prove amenable to immunogenetic modification
of susceptible amphibian species, the situation might change,
but it will also open up new ethical issues for conservationists
[60–62]. Clearly, it is imperative to continue investigating the
genetic basis of amphibian resistance and novel means by
which it can be augmented.
At least three published studies have investigated
whether frogs could be immunized against Bd. Systemic
injections of killed Bd were ineffective at reducing the prob-
ability of infection or death [63,64]. By contrast, increasing
numbers of exposures to killed Bd or live Bd culture followed
by clearance with antifungals was negatively correlated with
strength of infection and positively correlated with survival
following subsequent exposure to Bd [65]. The authors them-
selves questioned how their findings might be applied in a
conservation setting but noted the potential for priming
hosts against infection prior to release to the wild. These find-
ings are contradicted by Hudson et al., where the repeated
use of antifungals on naturally infected frogs generated no
long-term benefits once antifungal treatments ceased [17].
Perhaps more importantly, every immunization study to
date has focused on post-metamorphic animals, and immu-
nization of pre-metamorphic stages might not be possible
as adaptive immunity is not available to pre-metamorphic
stages [66] (but see [54]). Amplification of infection is com-
monly associated with larval stages, with high rates of
mortality occurring at metamorphic climax. Controlling
infection in amphibian larvae will be a key factor in mitigat-
ing impacts of chytridiomycosis because amphibian
population growth rates are highly sensitive to survival
rates of post-metamorphic juveniles [67–70].
The ideal vaccine for in situ use should elicit a strong pro-
tective response across life stages and across species against a
broad spectrum of relevant and virulent chytrid genotypes, be
safe, and have both its production and administration feasible.
Indeed, the research process should engage with the relevant
authorities from the outset, as policy applicable to vaccinating
free-living wildlife populations also requires development. So
far, immunization experiments have been conducted with
fairly straightforward and crude fungal preparations. Design-
ing effective vaccines is a time- and money-consuming
undertaking, and for diseases in a range of species, fungal vac-
cines have proved far more difficult to develop than their
bacterial and viral counterparts. To date, with few exceptions,
potential vaccines against human fungal pathogens are still inpreclinical stages of development and very few effective veter-
inary vaccines are available [71–73]. Although vaccinations
currently afford no clear contribution to chytridiomycosis miti-
gation in wild populations, continued research on vaccines
will undoubtedly aid in our understanding of amphibian
immunity and host–pathogen interactions, both topics
essential for a variety of mitigation strategies including
immunization, selection and bioaugmentation.
Manipulating environments to reduce infectivity or viru-
lence of Bd is another strategy that may hold promise. The
principle behind this ecological, rather than evolutionary,
approach underlies environmental treatments (e.g. see [27]),
but in practice is accomplished by exploiting environmental
variations that reduce chytrid growth and zoospore density
and does not require elimination of the pathogen from the
environment. The concept follows the recognition that
environmental variability can inhibit, as well as exacerbate,
the impacts of chytridiomycosis, with evidence of reduced
virulence even in highly susceptible host species [6,74–77].
Refuges from disease, but not necessarily infection, could
be created by altering habitats to reinforce environmental
factors not conducive to Bd growth within the host or zoos-
pore survival outside of it. Habitat management is already
integral to most amphibian conservation programmes and
often involves repeated efforts to maintain useful habitats
(e.g. [78]), suggesting that environmental manipulations for
the purposes of disease control could have quick uptake by
the conservation community, with both concepts and strat-
egies readily transferrable. Interventions could be chemical
(e.g. altering salinity), physical (e.g. altering temperatures
to not favour chytrid growth and reproduction) or biotic
(e.g. promoting the abundance of organisms that consume
environmental zoospores) [76,79–81]. These strategies will
probably focus, at least initially, on manipulating the aquatic
environment, as environmental persistence of Bd in water is
deemed essential for amphibian decline and extinction scen-
arios [82,83]. Theory and empirical evidence shows that
conservation efforts targeting aquatic life stages that reduced
disease-driven losses of newly metamorphosed juveniles
should improve recruitment and reduce or reverse the effects
of disease-driven decline; additional population models
addressing this topic are clearly needed [15,82,84].
Although environmental manipulations may create
pockets of tolerance or resistance, they offer limited opportu-
nities for amphibians with broad geographical ranges
and/or disproportionately affected complex communities
and habitats. As with environmental disinfection, even
in simple settings environmental manipulations must be
assessed for their impacts on biodiversity and other eco-
system functions. As with translocations/reintroductions,
host ecology must be well understood before changes to the
habitat are undertaken. For now, environmental manipu-
lation might provide long-term refuges for focal species
of high conservation concern, but offers no broad scope for
chytridiomycosis mitigation.
A focus on disease mitigation may not always be the best
way forward because simpler actions might achieve the
required results: improving habitat quality might enable
losses from disease at one stage of the amphibian life cycle
to be compensated for in gains at other life stages. For
example, one might use pond draining to cull predators of
amphibian larvae. As a consequence, tadpole survival
might increase, leading to increased juvenile recruitment.
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Clearly, we do not know how to manage amphibian diseases
in the wild and yet conservation managers have to make
decisions and manage populations. They cannot wait until
we understand amphibian-chytrid host–pathogen biology in
great detail; a lack of action because of imperfect information
is a management decision [86]. From our review, it is clear
that a single strategy is unlikely to achieve the conservation
outcome of disease mitigation. Each strategy has pros and
cons but by combining methods strategically in situ mitigation
is likely to have a greater probability of success. There are a
number of tools to decide which management actions are
best or most likely to succeed in the presence of uncertainty.
Structured decision-making and value of information analysis
can be used to find the best management option and to define
the direction of research most likely to illuminate critical uncer-
tainties [87–89]. For example, structured decision-making
might identify important gaps in our understanding of
chytrid epidemiology. These approaches have only recently
been used in the context of chytrid mitigation [7,24]. Converse
et al. used such an approach to study the effects of transloc-
ations in a toad metapopulation and found that efforts to
reduce disease spread had weak effects, selection for resistance
would increase the number of sites occupied by toads and
translocations would speed up species recovery [7].
Shortcomings of individual strategies outlined above may
be compensated for by combining two or more strategies. In
that sense, our outline of the major alternatives for Bd mitiga-
tion and the applicability and challenges of each forms a
starting template that can inform decision-making processes.
The science of decision-making links management options to
measurable objectives (e.g. population persistence). Post-
management monitoring then determines the outcome of
management actions against the objectives and is used to
update models for the next round of decision-making. This
approach allows real-time assessment of the impact of man-
agement alternatives so that management can be rapidly
modified to improve outputs [8,90].
For these approaches to work, researchers investigating
mitigation strategies have to engage in the conservation man-
agement process and be willing to alter research programmes
based on the outputs of structured decision-making and adap-
tive management exercises. Precedence for this can be found in
the literature on chytridiomycosis ecology, evolution and
epidemiology and is exemplified by the initial effort to identify
chytridiomycosis as the cause of amphibian mass mortality [2].
Coordinating research and management efforts have already
been proposed for Australian amphibian species at risk from
chytridiomycosis [6]. Joined-up efforts will require field trials
across a more extensive range of settings and amphibian
communities than are currently being attempted. It remains
to be decided, the authors of this review disagree on this
point, at which stage of methods development sufficient
knowledge has accumulated to justify field trials.What must be considered at all stages of the conservation
management process, however, are the ethical and legal
issues associated with whatever strategies are proposed or
adopted. Strategies that are illegal or unethical are inapplic-
able irrespective of their cost- and field-effectiveness,
reliability, transferability or simplicity. Ethical issues may
be identified at any scale. Our example of conservation
triage is a knotty ethical question: what is an acceptable
format for deciding which species to conserve and which to
cull or allow to go extinct? Expending effort on the mitigation
of chytridiomycosis should also be subject to ethical consider-
ation, as should any decision to expend highly limited
resources available for biodiversity conservation [91]. Disease
as a conservation issue remains a novel concept for most
policy-makers and conservation practitioners, so legal frame-
works may have to be challenged and modified to account
for responses to this new and growing threat to amphibian
biodiversity. Ethical issues may be difficult to address, but
failing to mitigate chytridiomycosis, a disease widely
accepted as predominantly driven by human activities, is
the least ethical option of all.5. Conclusion
Despite decades of research into amphibian-chytrid host–
pathogen biology, no effective method to reduce the impact
of chytridiomycosis has emerged and been tested broadly
in the field. A few case and proof-of-concept studies have
produced mixed or limited success at best. A more collabora-
tive approach to chytrid mitigation research is necessary, one
that should start with an approach from the family of tools
from decision sciences to define the most important research
questions. Such exercises to identify those questions should
be conducted by interdisciplinary research teams that are
working with conservation managers and that can put
research outputs into the context of the overall conservation
objectives. It is always uncertain how the findings of research
undertaken away from the field setting will transfer to the
real world, but it is clear from our review that significant
ex situ research efforts are required for all mitigation methods
to ensure that the results of field trials can be fully explained.
A lack of in situ evidence from chytridiomycosis mitiga-
tion efforts, however, indicates that field trials are not
yet an objective in many research programmes, despite
invoking amphibian conservation as a potential consequence
of research discoveries. Clearly, if we are to mitigate chytri-
diomycosis, research must be focused on delivering outputs
that can be rapidly and critically assessed and, when
warranted, implemented in field trials as soon as possible.
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